Crossref
Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism
MEDS Clinical Medicine · 2026 · 7 (1)
DOI: 10.23977/medsc.2026.070109 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Clinical Medicine, 2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism. MEDS Clinical Medicine, 7(1). https://doi.org/10.23977/medsc.2026.070109
Vancouver
Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism. MEDS Clinical Medicine. 2026;7(1). doi:10.23977/medsc.2026.070109
BibTeX
@article{euvimed2026,
title = {Tumor metabolic reprogramming driven by ARID1A deficiency and synthetic lethal mechanism},
journal = {MEDS Clinical Medicine},
year = {2026},
volume = {7},
number = {1},
doi = {10.23977/medsc.2026.070109}
}
EUVIMED